This federal contract award, valued at $12,881.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ozempic, a 1 mg/dose (4 mg/3 ml) 3 ml medication, with a completion date of December 3, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure.
Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
The contract award does not have a set-aside designation, indicating open competition. As a major supplier of pharmaceutical and medical products to federal agencies, Amerisourcebergen's federal contract awards demonstrate its critical role in supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 3/9/25, 12:46 AM